People with low birth weights could be at increased risk of developing impaired glucose tolerance (IGT) and Type II (non-insulin-dependent) diabetes mellitus later in life and this effect could be augmented in those who become overweight as adults [1, 2] . Impaired glucose tolerance or fasting hyperinsulinaemia have been shown in children during the first decade of life [3±6] and in young adults who had low birth weight [7] . The influence of postnatal growth on subsequent glucose and insulin concentrations has received little attention, although two studies [1, 6] suggest that growth during infancy or childhood as well as during fetal life can influence the risk of later IGT and Type II diabetes.
Aims/hypothesis. To test the hypothesis that small size for gestation and poor postnatal growth in preterm infants is associated with higher fasting and post-load plasma glucose and insulin concentrations at 9±12 years of age. Methods. Prospective follow-up at 9±12 years of 385 preterm children with birth weight less than 1850 g, who had anthropometry recorded at birth, 18 months and 7 years. Fasting plasma glucose, insulin, proinsulin and 32,33 split proinsulin concentrations and glucose and insulin concentrations 30 min after a standard glucose load were measured. Results. Post-load glucose concentrations were negatively related to birth weight, independently of gestation or subsequent growth. Fasting split proinsulin and 30-min insulin concentrations were highest in children who showed the greatest increase in weight centile between birth and current follow-up, regardless of gestation. When weight during childhood was included, birthweight centile was, however, no longer statistically significant: concentrations of fasting, split, proinsulin and 30-min insulin were highest in those children who had shown the greatest increase in weight centile between 18 months of age and current follow-up, with no evidence of a greater effect in those who were smallest at 18 months. Conclusion/interpretation. Our findings suggest that fetal growth influences plasma glucose 30 min after a glucose load in preterm children at 9±12 years. In contrast, childhood weight gain is the most important factor influencing insulin concentrations and this effect is the same regardless of early size. [Diabetologia (2000) 43: 714±717] Keywords Type II diabetes mellitus, preterm infant, childhood, glucose, insulin, birth weight, growth.
We measured fasting glucose and insulin and the response to an oral glucose load in preterm children at 9±12 years, to examine: the relation between gestation and size for gestation and later glucose and insulin concentrations and the effect of postnatal growth on later glucose and insulin concentrations.
Subjects and methods
Children were recruited from a cohort of 926 infants from five neonatal units in the United Kingdom [8] enrolled in a randomised multicentre trial of nutrition in preterm infants between 1982 and 1985. All weighed less than 1850 g at birth.
Weight was recorded at 18 months and 7 years post-term.
Of these children 503 (61.9 % of survivors) participated in the current study at 9±12 years of age and were seen by one of two investigators at their local hospital or surgery. Blood was taken between 0900 hours and 1800 hours (median 1230 hours) after a minimum 6-h fast. Eutectic mixture of local anaesthetics (EMLA) (Astra Pharmaceuticals, Slough, UK) cream was applied before venepuncture. If the child consented, the needle was taped in place and a glucose load (1.75 g/ kg up to a maximum 75 g) given as lucozade (Smith Kline Beecham, King's Langley, UK). A second blood sample was obtained after 30 min. Samples were separated and frozen at ±70°C within 45 min. Weight and height were measured. Pubertal status was self-assessed from photographs. Details of any relatives with Type II diabetes were recorded.
Ethical approval was obtained from the committees of the Dunn Nutrition Unit and the original participating centres. Written parental consent was obtained and verbal consent from each child.
Plasma glucose and insulin concentrations were measured as described previously [1] .
Statistics. Glucose concentrations were normally distributed. Insulin concentrations were normalised by transformation to natural logarithms. Standard deviation scores (SDS) for birth weight, weight at 18 months, weight at 7 years and current weight and height were calculated using British growth reference data.
To examine the influence of size at birth and subsequent growth on later glucose and insulin, four sequential regression models were used in which biochemical measurements were regressed on: (1) current size, (2) early size, (3) early and late size and (4) early and late size plus the interaction between the two [9] . A p value of less than 0.05 was regarded as significant. Current size and biochemical measurements are shown in Table 1 . Of the subjects seen 46 (23 %) boys and 78 (42 %) girls were pubertal (Tanner Stage 2 or above). Girls had statistically significantly higher insulin concentrations than boys and boys had higher fasting and 30-min glucose. Sex differences persisted in all subsequent analyses; they were reduced but not removed when pubertal children were excluded. Age and time of sampling were independently associated with glucose and insulin and were included in all regression models.
Weight SDS showed a strong positive relation with fasting and 30-min insulin (p < 0.001) and with fasting glucose (p = 0.007). Relations between height SDS and biochemical measurements were similar. The 30-min glucose was negatively associated with current weight and, more strongly, with current height.
Birth weight was negatively associated with 30-min glucose (coefficient ±0.0012, p = 0.009) before and after adjusting for gestation. Birthweight SDS was negatively associated with 30-min glucose (coefficient ±0.28, p = 0.013) but only after adjusting for gestation, which was itself not significant. Fasting glucose showed no relation with birth weight SDS or birthweight, before or after adjusting for current size.
There was no significant relation between birthweight SDS and insulin concentrations. After adjusting for current size, both split proinsulin and 30-min insulin were, however, negatively associated with birthweight SDS [regression coefficients (95 % CI) ±7.1 (±13.6 to ±0.7); ±7.9 (±14.6 to ±1.1), respectively adjusted for sex, gestation, sample time and current age]. Thus, for children with the same birth weight SDS, those with the greatest increase in weight SDS between birth and current follow-up have the highest insulin. There was no significant interaction between birth weight and current-weight SDS on insulin concentrations. Gestation and thinness at birth were not associated with later glucose or insulin and there was no interaction between birthweight SDS and gestation.
Current weight had a much greater effect on plasma insulin than birth weight. A 1 SD increase in current-weight SDS was associated with a 25.6 % increase in 30-min insulin and a 31.7 % increase in split proinsulin whereas the effect of a 1 SD increase in birth weight SDS was to decrease 30-min insulin by 7.9 % and split proinsulin by 7.1 %.
Growth during the immediate postnatal period (but still before term) was unrelated to later glucose or insulin, and adjusting for it did not alter the effect of birthweight SDS already described. Of the children studied at 9±12 years [366] had weight recorded at 18 months corrected age and 367 at 7 years. Birth weight SDS, 18-month and 7-year weight SDS were incorporated in a stepwise regression model with current size (Table 2) . Fasting glucose and all insulin measurements showed a positive relation with current weight SDS. All insulin concentrations showed significant negative relations with 18-month weight SDS and, for split and proinsulin, also with 7-year weight SDS. There was, however, no relation between birth weight SDS and insulin after adjusting for later growth. In this model 30-min glucose showed no relation with weight SDS at any age but was negatively related to birth weight. Thus, although current weight strongly and positively predicts insulin concentrations at 9±12 years, for children of equivalent current weight, insulin concentrations are higher in those with the greatest increase in weight SDS between 18 months and current follow-up. Of the 367 children 204 (56 %) had lower weight SDS at 18 months than they had at birth. The pattern of growth between birth and 18 months did not, however, influence insulin concentrations at 9±12 years.
There was a significant positive interaction between weight SDS at 18 months and current weight SDS on fasting and 30-min insulin and between weight SDS at 7 years and current weight SDS on split and proinsulin, suggesting that the effect of gain in weight SDS on insulin concentrations is greater in children who were heaviest earlier in childhood.
Results were not altered by excluding either firstly children whose mothers had gestational diabetes or insulin-dependent diabetes (n = 5) or secondly children born at more than 33 weeks gestation or by adjusting for social class at birth, parity, family history of Type II diabetes in a parent or grand-parent (n = 60) or current pubertal status (prepubertal versus pubertal).
Discussion
Low birth weight, whether due to prematurity or in utero growth restriction, was associated with higher plasma glucose 30 min after a glucose load in preterm children, independently of the pattern of growth during childhood. This finding, which is similar to that reported in term children [3±5], was independent of gestation suggesting that the critical period for this fetal programming effect could be before 25 weeks of gestation.
In contrast, plasma insulin concentrations were more strongly associated with the pattern of childhood weight gain than with growth in utero. Higher insulin concentrations were seen in children with the greatest increase in weight SDS (equivalent to upward centile crossing) between 18 months and current follow-up. That adjusting for size at an interim point in childhood removed the association between birth weight SDS and later insulin concentrations raises the possibility that, in other studies, birth weight might be acting as a proxy for a later, more influential weight (had the latter been available it might have altered the findings). Certainly our results shift the probable critical period for this particular effect forward from fetal life to childhood. A potential explanation for our findings is that the children who showed the greatest increase in weight centile between 18 months and the current follow-up were those who had entered puberty. Plasma insulin concentrations increase up to 13 years of age, with a peak just before the pubertal growth spurt in girls. Our results were, however, the same when pubertal children were excluded or after adjusting for pubertal status.
The interpretation of glucose and insulin concentrations in childhood cannot automatically be assumed to be the same as in adults. A full 2-h glucose tolerance test was considered unacceptable in these healthy children. In adults, glucose concentrations at 30 min are, however, related to those at 120 min, and it is the immediate insulin response to a glucose load which determines glucose tolerance.
In conclusion, our results suggest that, at least in preterm children, there are different critical periods for the programming of glucose tolerance and insulin resistance. Glucose tolerance is associated with size at birth, whereas insulin concentrations are associated with the pattern of weight gain during childhood. Our findings could differ from those of other investigators for a number of reasons. Firstly, we studied preterm children whose in utero experience could have differed from that of term infants and who showed greater variation in postnatal growth. Secondly, we interpreted our data differently from previous investigators, including testing for interactions between growth measurements at different timepoints on later outcome as proposed recently [9] . Thirdly, we incorporated interim measures of growth during childhood which have either been unavailable or not analysed in many other studies. The finding that an increase in weight SDS during early to midchildhood could be associated with hyperinsulinaemia is worrying in the context of an increasing prevalence of childhood obesity. Further investigation of other cohorts of children whose growth has been measured prospectively, including those born at term, is required to confirm or refute our findings.
